Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ekso Bionics Holdings Inc    EKSO

Delayed Quote. Delayed  - 11/17 10:00:00 pm
2.39 USD   +25.13%
11/09 EKSO BIONICS : Ford, Ekso team up for 'bionic' auto workers
11/09 EKSO BIONICS : Ford, Ekso team up for 'bionic' auto workers
11/09 EKSO BIONICS : reports 3Q loss
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Ekso Bionics : Ford, Ekso team up for 'bionic' auto workers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/09/2017 | 11:40pm CET
Ford Motor Co assembly worker Paul Collins wears a EksoVest as he works on the assembly line producing the Ford Focus and C-max at Wayne Assembly plant

Robots have replaced many U.S. manufacturing workers, but new mechanical exoskeletons being tested by Ford Motor Co (>> Ford Motor Company) may help factory workers to function like bionic people, reducing the physical damage of millions of repetitive tasks over many years.

Robots have replaced many U.S. manufacturing workers, but new mechanical exoskeletons being tested by Ford Motor Co (>> Ford Motor Company) may help factory workers to function like bionic people, reducing the physical damage of millions of repetitive tasks over many years.

The U.S. automaker said on Thursday that workers at two U.S. factories are testing upper-body exoskeletons developed by Richmond, California-based Ekso Bionics Holdings Inc (>> Ekso Bionics Holdings Inc), which are designed to reduce injuries and increase productivity.

The four EksoVests were paid for by the United Auto Workers union, which represents hourly workers at Ford, and the automaker plans tests for the exoskeleton in other regions including Europe and South America. The cost of the exoskeletons, which were developed as part of a partnership between Ford and Ekso, was undisclosed.

Two workers at each of the company's Wayne and Flat Rock factories have been testing the exoskeletons since May.

The lightweight vest supports workers while they perform overhead tasks, providing lift assistance of up to 15 pounds (6.8 kg) per arm through a mechanical actuator that uses torque to take the stress off a worker's shoulders.

If you try one on, if feels like an empty backpack, but it enables you to hold a weight such as a heavy wrench straight out in front of you indefinitely and without strain.

Ekso began by developing exoskeletons for the military and medical fields, but branched out in manufacturing and construction in 2013.

Paul "Woody" Collins, 51, a worker at Ford's Wayne plant, has been at the automaker for 23 years and has worn an EksoVest since May. He attaches bolts and parts to the undersides of Ford Focus and C-Max models, raising his hands above his head around 1 million times a year.

Since wearing the vest, he has stopped having to put ice and heat on his neck three or four days a week and finds he has energy after work instead of feeling exhausted.

Russ Angold, Ekso's chief technology officer, said the aim is to get workers used to the technology before moving eventually into "powered" exoskeletons that "will help with lift and carry" work.

"The idea is to demonstrate this isn't science fiction, it's real and it has real value," Angold said on Thursday. "As we prove its value, we will be able to expand into other tasks."

The No. 2 U.S. automaker has been studying for years how to lower its workers' injury rates and the exoskeleton venture is the latest step in that process.

From 2005 to 2016, Ford recorded an 83 percent decrease in injuries or incidents that resulted in days away, work restrictions or job transfers, to a rate of 1.55 incidents per 100 full-time employees.

That is a little over half the rate of 2.9 cases per 100 workers for private employers in 2016, according to U.S. government data.

"We have made great progress, but shoulders are still our number one injury and they take a lot of time to heal," Marty Smets, the Ford ergonomics engineer in charge of testing the exoskeletons, said on Thursday..

Collins, the Ford worker in Wayne, was supposed to wear the vest only until August, but has now asked to keep it.

"If they want it back now, they're going to have to fight me to get it off," he said.

(Reporting by Nick Carey; Editing by Matthew Lewis)

By Nick Carey

Stocks treated in this article : Ford Motor Company, Ekso Bionics Holdings Inc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EKSO BIONICS HOLDINGS INC
11/09 EKSO BIONICS : Ford, Ekso team up for 'bionic' auto workers
11/09 EKSO BIONICS : Ford, Ekso team up for 'bionic' auto workers
11/09 EKSO BIONICS : reports 3Q loss
11/08 EKSO BIONICS : Management's Discussion and Analysis of Financial Condition and R..
11/08 EKSO BIONICS HOLDINGS, INC. : Results of Operations and Financial Condition, Fin..
11/08 Ekso Bionics Reports Third Quarter 2017 Financial Results
11/08 EKSO BIONICS HOLDINGS INC : Ekso Bionics Holdings, Inc. to Host Earnings Call
11/01 Ekso Bionics® to Report Third Quarter 2017 Financial Results on November 8, 2..
10/11 EKSO BIONICS : to Showcase the Latest Features of the EksoGT Wearable Exoskeleto..
10/10 Ekso Bionics® to Showcase the Latest Features of the EksoGT™ Wearable E..
More news
News from SeekingAlpha
11/17 Midday Gainers / Losers
11/17 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
11/14 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
11/14 PREMARKET LOSERS AS OF 9 : 05 am
11/13 Midday Gainers / Losers
Financials ($)
Sales 2017 8,09 M
EBIT 2017 -29,2 M
Net income 2017 -28,8 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 7,62x
Capi. / Sales 2018 3,63x
Capitalization 61,7 M
Chart EKSO BIONICS HOLDINGS INC
Duration : Period :
Ekso Bionics Holdings Inc Technical Analysis Chart | EKSO | US2826442020 | 4-Traders
Technical analysis trends EKSO BIONICS HOLDINGS INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 3,00 $
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Thomas Looby President, Chief Executive Officer & Director
Steven Sherman Chairman
Russell L. DeLonzor Vice President-Operations
Max Scheder-Bieschin CFO & Principal Accounting Officer
Russ Angold Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
EKSO BIONICS HOLDINGS INC-39.95%62
MEDTRONIC PLC11.60%107 676
BAXTER INTERNATIONAL44.07%34 804
C R BARD INC48.47%24 314
ZIMMER BIOMET HOLDINGS INC8.15%22 598
ALIGN TECHNOLOGY164.11%20 356